Article Name Medical Finance
The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue
15th January, 2026
ew capital dedicated to acquiring commercial-stage surgical product companies. The investment will be managed within MedEdge Holdings LLC. This newly formed holding company will use its ownership of Abyrx and Kairuku as the foundation for a broader growth strategy.
26th November, 2025
Net revenues rose 52.2 per cent to $1,404,000, driven by strong VIVID product demand within the Torbal Division
20th November, 2025
Only 0.5% of multilateral climate finance goes to health, despite climate change projected to cause up to 15.6 millions deaths by 2050.
11th November, 2025
Through this expansion, laboratories will have direct access to Colaborate's consulting expertise, combined with the reliability and reach of Henry Schein's network and lab capabilities
10th September, 2025
The ProVee System uses a nitinol stent designed to gently reshape the enlarged BPH prostate and alleviate the associated lower urinary tract symptoms
25th August, 2025
Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and including the Undisturbed Date, and exceeds the highest closing price as quoted on the Stock Exchange since 2022 The proposed privatisation will be effected by way of a scheme of arrangement; the Offeror Concert Parties collectively hold 74.75% shares in the Company; an Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the Proposal The Proposal presents shareholders with certainty over their ability to monetise their interests in Kangji Medical Holdings Limited, following a period of sustained pressure on trading prices and limited liquidity
13th August, 2025
Diagnostic imaging leads revenue surge; Novena centre expands reach in preventive healthcare
13th August, 2025
Funding boost to support pivotal trial and pre-commercialization of CLAAS® AcuFORM™ LAAO system.
13th August, 2025
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.
31st July, 2025
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.
29th July, 2025
Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care.
25th July, 2025
The platform sets out to transform India’s healthcare system by investing in high-impact solutions focused on access, affordability, and digital advancement.
06th June, 2025
SFPIM and Existing Shareholders Back Strategic Funding to Support Liver Disease Therapy Advancements.
27th May, 2025
New investment to accelerate global rollout of Koning’s 3D breast imaging technology.
23rd May, 2025
Innovative high-frequency energy technology aims to revolutionize onychomycosis care with a drug-free, patient-friendly solution.
16th May, 2025
Funding to Fuel Commercial Scale-Up and Launch of New Ortho EDG Surgical Instruments in U.S. and International Markets.
12th May, 2025
Vitrolife AB Leads Syndicated Funding to Accelerate Development of AutoIVF’s Automated In Vitro Fertilization Platform
12th May, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer